Lipid abnormalities remain to be a major cause of early mortality in patients with chronic renal failure (CRF). In present study, 114 (one hundred fourteen) CRF patients without any additional cause of dyslipidemia were divided into groups on the basis of etiologies of CRF. Blood samples from each group were analyzed for total cholesterol, triglyceride and HDL cholesterol along with blood urea nitrogen and serum creatinine. 25 healthy individuals without any obvious disease were taken as control. Patients from all the groups showed a marked hypertriglyceridemia of 232 (SD + 77) mg/dl (P < 0.001) as compared to control. Levels of HDL cholesterol were found to be significantly low 20 ( ~ 11) mg/dl (p < 0.001) in all the groups. LDL cholesterol showed an increase 104 ( _+ 30) mg/dl as compared to control group which is not statistically significant. Present study reveals that, CRF patients show an uniform dyslipidemia irrespective of etiologies leading to CRF. This dyslipidemia is also independent of serum creatinine levels. Although, these lipid abnormalities may not solely cause mortality in CRF patients, they may act as modulators in accelerating atherogenesis which in turn cause early mortality in CRF patients.
INTRODUCTION
Dyslipldemia, Atherogenesis.
Lipid abnormalities in CRF patients have been reported since long. Hypertdglyceridemia isthe most common lipid abnormality in patients with renal failure (1) . The major cause of death in about 30-65% of CRF patients is atherosclerotic cadiovascular disease with various predisposing factors like diabetes mellitus, essential hypertension and proteinuria (2) . Abnormalities of liptds and lipoproteins occur early in clinical course of patients, but they are not always reflected by hyperlipidemia. Prospective studies suggest that, dietary and/or pharmacological intervensions of lipids and Ilpoproteins provide beniefical effects on cardiovascular events (3). It is not clear that, underlying lipid abnormalities are linked to renal impairments. The mechanisms which contribute to lipid abnormalities in CRF patients are not clearly understood. It is possible that, there is a genetic link between the two abnormalities, or kidney themselves play an important role in lipid metabolism which is disturbed by onset of proteinuria (4) . Increased LDL levels, decreased HDL levels have been reported in patients with diabetes and microabuminuria. Nondiabetic patients with overt proteinuria also have marked lipid abnormalities (5).
The aim of present study is to further elucidate relationship between dyslipidemia and various etiologies which lead to chronic renal failure.
MATERIALS AND METHODS

Study subjects :
114 patients with end-stage renal disease (ESRD) aged 25-65 years were admitted in the nephrology ward of Choithram Hospital & Research Centre. These patients (86 men & 28 women) were divided into various groups on the basis of etiologies which resulted in end-stage renal disease. These groups were : (i) Chronic Glomerulonephritis (CGN) with CRF (n = 31), (U) Chronic Interstitialnephritis (CIN) with CRF (n = 26), (iii) Hypertensive Nephrosclerosis (HTN) with CRF (n = 17), (iv) Diabetic Nephropathy with CRF (n = 26), (v) Others (n = 14) which included patients with renal calculas disease, Polycystic kidneys and cancer of some organ resulting in CRF and (vi) Acute renal failure (ARF) (n = 10). Patients receiving hemedialysis, beta blockers, Angiotensin Converting Enzyme (ACE) inhibitors, androgens or any drugs affecting lipid metabolism were excluded from study.
25 healthy volunteers aged 30-55 years who had no previous history of diabeteS, dylipidemia or any other disease were taken as control. Fasting blood of these subjects was analyzed for cholesterol, triglyceride and HDL cholesterol-to establish the normal range.
Estimation of blood constituents
Fasting blood was obtained from all the patients. Blood urea nitrogen and serum creatinine were measured by Urease GLDH Kinetic and Jaffe' Kinetic method respectively on autoanalyzer to assess renal functions.
Total cholesterol was measured byCHOD-PAP method and triglyceride was measured byTrig-G PO-P A P method respect ively utilizing reagents ma n ufactured by Boehringer Mannheim Ltd., Mannheim, Germany, on Hitachi-704 autoanalyzer, HDL cholesterol was measured by CHOD-PAP Method using phosphotungstic acid and magnesium chloride as precipetating reagents, on autoanalyzer, LDL cholesterol was calculated by Friedewald formula (6).
Statistical analysis were performed using unpaired student's t-test calculating significance for each group.
RESULTS
Patients divided into various groups on the basis of etiologies which led to CRF showed a significant hypertdglyceridemia HDL Cholesterol levels were also significantly reduced (table 1) in all the groups as compared to control group.
Patients with chronic glomerulonephritis (n = 31 ) showed cholesterol levels in upper normal range. Hypercholesterolimia was observed in few cases irrespective of triglyceride levels. The ratio of total cholesterol to HDL Cholesterol, the risk ratio was 2.6 times higher as compared to control group. The patients with chronic interstitial nephritis (n = 26) also showed similar results. The risk ratio was 2.5 times higher as compared to control group. Patients with hypertensive nephrosclerosis (n = 17) showed a marked hypercholesterolimia (p < 0.01). LDL cholesterol levels were also increased (P < 0.01). Patients with diabetic nephropathy (n = 26). Showed highest triglyceride and lowest levels of HDL cholesterol as compared to the rest of the groups. Risk ratio was 3.0 times higher as compared to control group.
In the present study, it is clear that patients with CRF show almost sllrnilar dyslipidemia irrespective of etiologies of CRF. Now, a question may arise about relationship between dyslipidemia and degree of renal dysfunction. Serum creatinine remains to be reliable source of assessment of renal function. So, patients of various groups were divided into subgroups on the basis of creatinine levels (table 2).
It is seen from table 2, that the altered values of various lipid parameters like total cholesterol, triglyceride and HDL cholesterol are not reflected by changes in the plasma creatinine levels.
DISCUSSION
Chronic renal failure is frequently associated with abnormalities of lipid metabolism. The mechanisms of these abnormalities in uremic patients are incompletely understood. Experimental studies suggest that nondiabetic subjects with overt proteinuria have marked lipid abnormalities. Increased LDL and decreased HDL have been reported earlier. There is a direct link between proteinuria and abnormalities of lipid profile. Non-diabetic subject with proteinuria have 5 fold increased risk of myocardial infraction (7) (8) . Autopsy studies have suggested singnificant relationship between global glomerulosclerosis and atherosclerosis (5) . In present study, analysis of data of lipid parameters obtained from 20 CRF patients who died within 3 months of this study suggest that, a sharp decrease in HDL levels can be an important pre-disposing factor of early mortality in CRF patients (Figure) .
Prospective studies also suggest correlation between hypertension & hyperlipidemia and they both influence progression of ESRD. There is a relationship between diabetes, hypercholesterolimia and loss of renal function (9-10).
Present study suggests that dyslipidemia is observed in CRF patients irrespective of etiologies and severity of renal dysfunction indicated by serum creatinine levels. All the CRF patients are at risk of accelerated atherosclerotic heart disease. 
